This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 2 CIPO patents. Top assignee: Kikkoman Corporation. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Akemi Kosaka: Innovator in Immunoregulation
Introduction
Akemi Kosaka is a prominent inventor based in Japan, recognized for her contributions to the field of immunoregulation. With a focus on innovative peptides and double-stranded RNA derived from lactic acid bacteria, she has made significant strides in medical applications.
Latest Patents
Akemi Kosaka holds patents related to two key innovations. The first is a cancer antigen peptide that comprises 10-45 amino acids, including specific sequences that activate helper T cells. This peptide can be utilized as a medicine or a helper T cell activator. The second patent involves an immunoregulator derived from lactic acid bacteria, which is safe and efficiently incorporated into cells. This double-stranded RNA serves as an active ingredient with immunoregulatory properties.
Career Highlights
Kosaka is affiliated with the National University Corporation Asahikawa Medical University, where she continues her research and development efforts. Her work has garnered attention for its potential impact on cancer treatment and immunotherapy.
Collaborations
She collaborates with notable colleagues, including Ikuko Masuda and Daisuke Kaneko, contributing to a dynamic research environment.
Conclusion
Akemi Kosaka's innovative work in immunoregulation and her dedication to advancing medical science highlight her importance in the field. Her contributions pave the way for future developments in cancer treatment and immunotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile